Gt Biopharma dropped to day and moved down -3.54%
The company isn't at an immediate support or resistance level that might be predictive. Gt Biopharma hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. GTBP might find some support at the 2.25 level, buyers might push the price back up from here. But it's not very clear what will happen.